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Heat Shock Protein as a
Mediator Between the Effects of
Corticosteroids on Atrial
Fibrillation Recurrence After
Catheter Ablation
Koyama et al. (1) conducted an excellent study on the prevention
of atrial fibrillation recurrence with corticosteroids after radiofre-
quency catheter ablation. However, the mechanism by which a
short course of corticosteroids for 3 days right after catheter
ablation could prevent long-term recurrence of atrial fibrillation
remains unclear and puzzling. Inflammation and atrial remodeling
during the early phase seem to play a role.
In reference to that, I would like to point out that corticoste-
roids could decrease atrial fibrillation recurrence by stimulating the
release of heat shock proteins (HSPs). Corticosteroids induce a
heat stress response with the release of HSPs (2). In an in vitro
model, artificially up-regulating HSP27 protects against atrial
remodeling, which was measured as calcium transient and cell
shortening (3). In a canine model, HSP induction attenuates
tachypacing-induced decreases in the effective refractory period
(ERP) (3). This study also demonstrated that remodeling changes
occur in as little as 4 h of tachypacing (3). In another study,
overexpressing HSP27 significantly reduced tachypacing-induced
myolysis (4).
So far, studies have shown that HSPs have cardioprotective
effects at an in vitro level in an animal model. Altering HSP
expression at a clinical level has not yet been studied, and it is
unclear whether it has any disease modification properties in
patients with atrial fibrillation. Future studies should focus on the
interactions between corticosteroids, HSPs, and the recurrence of
atrial fibrillation after cardioversion and catheter ablation. HSPs
could be a novel target for intervention in atrial fibrillation.*Chee Yuan Ng, MD
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Reply
We thank Dr. Ng for his constructive suggestions. Unfortunately,
we did not examine heat shock proteins (HSPs) in our study (1).
However, it is one of the important possible mechanisms that
HSPs induced by corticosteroids could prevent atrial electrical
remodeling through cardioprotective actions.
It is known that inflammatory responses are closely associated with
the occurrence or maintenance of atrial fibrillation (AF). AF occur-
rences are frequently observed after cardiac surgery. A previous study
suggested that inflammatory cytokines such as interleukin-6 (IL-6)
are involved in AF occurrences related to cardiac surgery (2). Halonen
et al. (3) provided strong evidence that short-duration and low-dose
corticosteroid could suppress AF onset after surgery. We believe that
the anti-inflammatory action of corticosteroids is an effective thera-
peutic approach to AF. It is commonly accepted that radiofrequency
catheter ablation is an effective therapeutic option for drug-refractory
AF. As mentioned in our study, catheter ablation procedures for AF
cause relatively large amounts of damage to the atrial tissue due to
radiofrequency energy (1). As a result, the acute inflammatory
response could be evoked after catheter ablation procedures. Very
recently, it was reported that interleukin-6–positive mononuclear cells
are recruited to atrial tissue and involved in the arrhythmogenic
substrate in the human atrium (4). We hypothesized that these
responses could occur in damaged cardiac tissue caused by catheter
ablation. This damage could cause infiltration of inflammatory cells
such as mononuclear cells. Additionally, these inflammatory re-
sponses could cause the electrical and structural remodeling via
pro-inflammatory cytokines after catheter ablation, resulting in
the AF recurrence. One possible mechanism is that corticoste-
roids suppress macrophage migration and its release of pro-
inflammatory cytokine, thus preventing AF recurrence after
catheter ablation.
Mandal et al. (5) provided an interesting study showing that
anti-HSP 65 was an important contributor to the risk of postop-
erative AF. St Rammos et al. (6) reported that atrial HSP levels
negatively correlate with AF incidence after cardiac surgery. These
results suggest that HSPs are an important suppressor of AF after
